Bristol-Myers Squibb
BMY
BMY
2,438 hedge funds and large institutions have $99B invested in Bristol-Myers Squibb in 2021 Q4 according to their latest regulatory filings, with 327 funds opening new positions, 860 increasing their positions, 1,006 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 64 → 64 (0)
1.19% less ownership
Funds ownership: 73.3% → 72.11% (-1.2%)
15% less repeat investments, than reductions
Existing positions increased: 860 | Existing positions reduced: 1,006
Holders
2,438
Holding in Top 10
64
Calls
$1.95B
Puts
$1.55B
Top Buyers
| 1 | +$362M | |
| 2 | +$278M | |
| 3 | +$187M | |
| 4 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
+$187M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$183M |
Top Sellers
| 1 | -$988M | |
| 2 | -$429M | |
| 3 | -$416M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$305M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$286M |